KMB vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

KMB

37.9
AI Score
VS
EMR Wins

EMR

52.9
AI Score

Investment Advisor Scores

KMB

38score
Recommendation
SELL

EMR

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric KMB EMR Winner
Forward P/E 13.1062 20.8768 KMB
PEG Ratio 1.986 1.7328 EMR
Revenue Growth 0.6% 7.0% EMR
Earnings Growth -32.3% 23.0% EMR
Tradestie Score 37.9/100 52.9/100 EMR
Profit Margin 11.8% 13.8% EMR
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD EMR

Relative Price Performance (Last 90 Days)

KMB 1M: -9.9% · 3M: -3.3% EMR 1M: -7.1% · 3M: +7.1%

Current Technical Phase

KMB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 29

RSI (14): 28.6 · Price: $98.15

EMR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.9 · Price: $152.19

Fundamentals Snapshot

Metric KMB EMR
Market Cap
Forward P/E 13.1 21.0
Trailing P/E 19.5 32.9
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.4% 0.5%
Operating Margin 0.2% 0.3%
EPS 5.05 4.51
Dividend Yield 0.05% 0.01%

Frequently Asked Questions

Based on our detailed analysis, EMR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.